USPTO serial 76682429
LAILIXIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SPRUILL, DARRYL M
- Law office
- TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LAILIXIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
XINCHANG ZHEJIANG, CN
Other trademarks owned by ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
XINCHANG ZHEJIANG, CN
Other trademarks owned by ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jack Matalon
JACK MATALON Law Offices of Jack Matalon32 SHELLEY RDSPRINGFIELD, NJ 07081-2529UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets; Ace-inhibitors; Adrenergic agonists; Adrenergic blockers; Anabolics; Analgesics, narcotic and non-narcotic analgesics; Anesthetics; Antianorexics; Antacids; Anthelmintics; Antiacnes; Antiallergics; Antianginals; Antiarthritics and antirheumatics; Antiasthmatics; Antibacterials; Antibiotics; Anticoagulants; Anticonvulsants; Antidepressants; Antidiabetics; Antidiarrheals; Antidiuretics; Antiemetics; Antifungals; Antiglaucomas; Antihistaminics; Antihypertensives; Antihyperthyroids; Antihypotensives; Anti-inflammatories; Anti-itch creams, ointments and sprays; Antimalarials; Antimigraines; Antimuscarinics; Antineoplastics; Antioxidants; Antiparkinsonians; Antiprotozoals; Antipruritics; Antipsoriatics; Antipsychotics; Antiseborrheics; Antiseptics; Antispasmodics; Antisyphilitics; Antithrombotics; Antitussives; Antiulceratives; Antivirals; Anxiolyties; Astringents; Bacteriostats for medicinal, dental and veterinary use; Bath salts for medical purposes; Beta-blockers; Biocides; Biological and chemical reagents for medical or veterinary use; Bronchodilators; Burn-relief medications; Calcium channel blockers; Cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; Chemotherapeutics; Choleretics; Cholesterol reducers; Cholinergics; Cholinesterase inhibitors; Cleansing solutions for medical use; Clinical medical reagents; CNS stimulants; Contraceptives; Decongestants; Dermatologicals; Diagnostic preparations for medical purposes; Dietary and nutritional supplements; Diuretics; Dopamine receptor agonists; Enzyme cofactors; Estrogens; Expectorants; Food supplements; Gastric and pancreatic preparations; Germicides; Glucosidase inhibitors; Gonad-stimulating principles; Hematinics; Hematopoietics; Hemostatics; Hepatoprotectants; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Homeopathic supplements; Immunomodulators; Immunosuppressants; Laxatives; Medicinal herbal extracts; Mineral nutritional supplements; Mineralocorticoids; Mixed vitamin preparations; Mucolytics; Multi-vitamin preparations; Muscle relaxants; Mydriatics; Neutraceuticals for use as dietary supplements; Nootropics; Nutritional additives to foodstuffs for animals, for medical purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Plant extracts for medical, veterinary and pharmaceutical purposes; Processed food adapted for medical purposes; Progestogens; Prolactin inhibitors; Prostaglandins and prostaglandin analogs; dietary supplements; Respiratory stimulants; Reverse transcriptase inhibitors; Sedatives; Seratonin receptor agonists and antagonists; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; Vasodilators; Vasoprotectants; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes | ACTIVE | Oct 27, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
- Other trademarks owned by ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
- Other trademarks in Class 005
- Similar marks named LAILIXIN
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2011 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 20, 2011 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 14, 2011 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 13, 2011 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 12, 2010 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2010 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 20, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2010 | PAPER RECEIVED | — | |
| Jul 1, 2010 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2010 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2010 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 5, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 19, 2010 | IUAF | USE AMENDMENT FILED | — |
| May 19, 2010 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 19, 2010 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 1, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 1, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 1, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 28, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 28, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 28, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 2, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 9, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 5, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 30, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 14, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 14, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 14, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 9, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 9, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 16, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 11, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jun 10, 2008 | FAXX | FAX RECEIVED | — |
| Jun 10, 2008 | FAXX | FAX RECEIVED | — |
| Jan 10, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 13, 2007 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 9, 2007 | NWAP | NEW APPLICATION ENTERED | — |